You have 9 free searches left this month | to do more

cpx-351

Cpx 351 is a drug used to treat Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic Syndrome (MDS), and other conditions. Cpx 351 is being actively studied in 19 studies and prior, has been studied in 8.

Top SponsorsTop SitesTop Investigators
Jazz PharmaceuticalsMedical College of WisconsinSudipto Mukherjee
Weill Medical College of Cornell UniversityWeill Cornell Medical CollegeDeepa Jeyakumar
Case Comprehensive Cancer CenterFred Hutchinson Cancer Research CenterLaura Michaelis
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
  • Acute Myeloid Leukemia
  • AML
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
2022-03-16
Mar 16, 2022
G
Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • CPX-351
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
2022-02-07
Feb 7, 2022
C
Recruiting
  • Refractory Acute Myeloid Leukemia
  • +2 more
  • CPX-351
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
2022-03-15
Mar 15, 2022
W
Active, not recruiting
  • Myelodysplastic Syndromes
  • CPX-351
  • +3 more
  • Tampa, Florida
  • +2 more
2022-04-01
Apr 1, 2022
Y
Withdrawn
  • MDS
  • CPX-351
  • New Haven, Connecticut
    Yale University; Smilow Cancer Center
2022-01-06
Jan 6, 2022
W
Active, not recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • CPX-351
  • +4 more
  • New York, New York
    Weill Cornell Medical College
2022-01-26
Jan 26, 2022
W
Active, not recruiting
  • Leukemia, Myeloid, Acute
  • CPX-351
  • New York, New York
    Weill Cornell Medical College
2021-12-10
Dec 10, 2021
C
Recruiting
  • Myelodysplastic Syndrome (MDS)
  • CPX-351
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
2021-04-21
Apr 21, 2021
J
Recruiting
  • Acute Myeloid Leukemia
  • CPX-351
  • Belfast, United Kingdom
  • +14 more
2022-04-05
Apr 5, 2022
J
Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +7 more
2021-08-23
Aug 23, 2021
J
Completed
  • Hematologic Malignancy
  • +4 more
  • CPX-351
  • Washington, District of Columbia
  • +12 more
2021-07-20
Jul 20, 2021
U
Recruiting
  • Acute Myelogenous Leukemia (AML) Due to Therapy
  • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
  • La Jolla, California
  • +2 more
2021-04-09
Apr 9, 2021
J
Active, not recruiting
  • Acute Myeloid Leukemia
  • CPX-351
  • +3 more
  • Duarte, California
  • +9 more
2022-03-07
Mar 7, 2022
W
Recruiting
  • Acute Myeloid Leukemia
  • CPX-351
  • Gemtuzumab Ozogamicin
  • New York, New York
    Weill Cornell Medical College
2021-12-21
Dec 21, 2021
C
Completed
  • Acute Myeloid Leukemia
  • +7 more
  • CPX-351
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
2020-11-06
Nov 6, 2020
M
Recruiting
  • Leukemia, Myeloid, Acute
  • Outpatient Care Model
  • CPX-351
  • Milwaukee, Wisconsin
    Froedtert Hospital
2021-05-24
May 24, 2021
H
Active, not recruiting
  • Lymphoid Leukemia
  • +3 more
  • CPX-351
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-09-14
Sep 14, 2021
B
Not yet recruiting
  • Acute Myeloid Leukemia
  • CPX-351
  • +5 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
2022-02-21
Feb 21, 2022
F
Not yet recruiting
  • Acute Myeloid Leukemia
  • Myeloproliferative Syndrome
  • CPX-351
  • Amiens, France
  • +33 more
2022-02-07
Feb 7, 2022
G
Recruiting
  • MDS
  • AML
  • CPX-351
  • +3 more
  • Linz, Austria
  • +26 more
2021-08-18
Aug 18, 2021
J
Completed
  • High Risk Acute Myeloid Leukemia
  • CPX-351
  • 7+3 (cytarabine and daunorubicin)
  • Birmingham, Alabama
  • +42 more
2020-07-28
Jul 28, 2020
J
Completed
  • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
  • Therapy-Related Acute Myeloid Leukemia
  • CPX-351
  • Indianapolis, Indiana
  • +6 more
2020-08-04
Aug 4, 2020